Low-dose Combination of Three Antihypertensive Drugs (3D)
Primary Purpose
Arterial Hypertension
Status
Unknown status
Phase
Phase 4
Locations
Italy
Study Type
Interventional
Intervention
Tripliam (perindopril, indapamide, amlodipine)
Reaptan (perindopril, amlodipine)
Sponsored by

About this trial
This is an interventional treatment trial for Arterial Hypertension focused on measuring arterial hypertension, antihypertensive drugs
Eligibility Criteria
Inclusion Criteria:
Patients with arterial hypertension resistant to monotherapy
Exclusion Criteria:
None
Sites / Locations
- Sapienza University
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
Three antihypertensive Drugs
Two antihypertensive drugs
Arm Description
Patients will be treated with Tripliam, that is a commercially available fixed low-dose combination of three antihypertensive drugs, that is 5 mg/daily perindopril, 1,25 mg/daily indapamide and 5 mg/day amlodipine
Patients will be treated with Reaptan, that is a commercially available fixed high-dose combination of two antihypertensive drugs, that is 10 mg/daily perindopril and 5 mg/day amlodipine
Outcomes
Primary Outcome Measures
Number of patients who reach target blood pressure
How many patients have blood pressure within normal limits
Secondary Outcome Measures
Full Information
NCT ID
NCT02710552
First Posted
March 4, 2016
Last Updated
March 16, 2016
Sponsor
University of Roma La Sapienza
1. Study Identification
Unique Protocol Identification Number
NCT02710552
Brief Title
Low-dose Combination of Three Antihypertensive Drugs
Acronym
3D
Official Title
Randomized Comparison of Fixed Low-dose Combination of THREE Antihypertensive Drugs Versus Fixed High-dose Combination of Two Antihypertensive Drugs in Arterial Hypertension (the 3D Trial)
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Unknown status
Study Start Date
April 2016 (undefined)
Primary Completion Date
March 2019 (Anticipated)
Study Completion Date
March 2020 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Roma La Sapienza
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of the study is to compare the efficacy and safety of low-dose combination of three antihypertensive drugs versus fixed high-dose combination of two antihypertensive drugs in arterial hypertension
Detailed Description
The aim of the study is to compare the efficacy and safety of commercially available low-dose combination of three antihypertensive drugs versus commercially available fixed high-dose combination of two antihypertensive drugs in arterial hypertension
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arterial Hypertension
Keywords
arterial hypertension, antihypertensive drugs
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
100 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Three antihypertensive Drugs
Arm Type
Active Comparator
Arm Description
Patients will be treated with Tripliam, that is a commercially available fixed low-dose combination of three antihypertensive drugs, that is 5 mg/daily perindopril, 1,25 mg/daily indapamide and 5 mg/day amlodipine
Arm Title
Two antihypertensive drugs
Arm Type
Active Comparator
Arm Description
Patients will be treated with Reaptan, that is a commercially available fixed high-dose combination of two antihypertensive drugs, that is 10 mg/daily perindopril and 5 mg/day amlodipine
Intervention Type
Drug
Intervention Name(s)
Tripliam (perindopril, indapamide, amlodipine)
Other Intervention Name(s)
Combination of three antihypertensive drugs
Intervention Description
Fixed combination of perindopril 5 mg, indapamide 1,25 and amlodipine 5 mg
Intervention Type
Drug
Intervention Name(s)
Reaptan (perindopril, amlodipine)
Other Intervention Name(s)
Combination of two antihypertensive drugs
Intervention Description
Fixed combination of perindopril 10 mg and amlodipine 5 mg
Primary Outcome Measure Information:
Title
Number of patients who reach target blood pressure
Description
How many patients have blood pressure within normal limits
Time Frame
From baseline to the end of the 3-month study period
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with arterial hypertension resistant to monotherapy
Exclusion Criteria:
None
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Francesco Pelliccia, MD
Phone
390649971
Ext
123
Email
md4151@mclink.it
First Name & Middle Initial & Last Name or Official Title & Degree
Cesare Greco, MD
Phone
390649971
Ext
123
Email
md4151@mclink.it
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carlo Gaudio, MD
Organizational Affiliation
Sapienza University
Official's Role
Study Chair
Facility Information:
Facility Name
Sapienza University
City
Rome
ZIP/Postal Code
00161
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Low-dose Combination of Three Antihypertensive Drugs
We'll reach out to this number within 24 hrs